Latest research data demonstrates CTC capture in hepatocellular carcinoma (HCC) patients using revolutionary technology ApoStream™ that detects all types of circulating tumor cells (CTCs); accelerates potential for personalized therapy of liver cancer HOUSTON (April 2, 2012) — Scientists at ApoCell, Inc., in partnership with researchers at Virginia Commonwealth University (VCU) […]

New technology could detect liver cancer from a simple blood sample Results from VCU Massey Cancer Center study suggest that ApoCell’s ApoStream® device effectively collects circulating liver cancer cells, has potential to advance diagnosis and treatment of the disease Richmond, Va. – (March 30, 2012) – New technology from ApoCell, […]

ApoCell, Inc. publishes data demonstrating capabilities of ApoStream ™ device for improved capture of circulating tumor cells (CTCs) HOUSTON (Nov, 2011) — Clinical trial data presented this week by ApoCell, Inc. demonstrated the capabilities of its new ApoStream™ device to isolate higher numbers of circulating tumor cells (CTCs) […]